BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Prognosis
921 results:

  • 1. Dynamic ctDNA-based analysis of drug-resistant gene alterations at RAS/BRAF wild-type metastatic colorectal cancer patients after cetuximab plus chemotherapy as the first-line treatment.
    Zhou YW; Zhao X; Ni L; Cao P; Leng WB; Zhu Q; Gou HF; Zhang J; Li XF; Qiu M
    Int Immunopharmacol; 2024 Apr; 131():111887. PubMed ID: 38503018
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Differential genetic mutations and immune cell infiltration in high- and low-risk STAD: Implications for prognosis and immunotherapy efficacy.
    Deng YY; Sun Y; Wu SJ; Zhang TY; Yang J; Liu K
    J Cell Mol Med; 2024 Apr; 28(7):e18174. PubMed ID: 38494839
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Negative prognostic impact of Co-mutations in TGFβ and tp53 pathways in surgically resected rectal tumors following neoadjuvant chemoradiotherapy.
    Qian C; Yang W; Li M; Feng Y; Dai N; Luo H; Jian D; Li X; Yang Y; He Y; Wang D; Li C; Xiao H
    Eur J Surg Oncol; 2024 Apr; 50(4):108242. PubMed ID: 38460248
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer.
    Liu H; Zhou D; Liu D; Xu X; Zhang K; Hu R; Xiong P; Wang C; Zeng X; Wang L; Zhang S
    Cell Death Dis; 2024 Mar; 15(3):187. PubMed ID: 38443386
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Primary vulvar adenocarcinoma of intestinal type: Report of two cases showing molecular similarity with colorectal adenocarcinoma.
    Mateoiu C; Palicelli A; Maloberti T; De Biase D; De Leo A; Lindh M; Bohlin KS; Stolnicu S
    Pathol Res Pract; 2024 Mar; 255():155181. PubMed ID: 38340583
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genetic specificity study using next-generation sequencing (NGS) of peritoneal metastatic colorectal cancer compared to primary colorectal cancer.
    Lee S; Shin W; Park DG; Namgung H
    Genes Genomics; 2024 Mar; 46(3):289-302. PubMed ID: 38316717
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer.
    Yang H; Xiao X; Zeng L; Zeng H; Zheng Y; Wang J; Li G; Dai W; He Y; Wang S; Peng J; Chen W
    J Transl Med; 2024 Feb; 22(1):132. PubMed ID: 38310289
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system.
    Chiba Y; Kagabu M; Osakabe M; Ito R; Sato S; Takatori E; Kaido Y; Nagasawa T; Shoji T; Yanagawa N; Baba T
    Jpn J Clin Oncol; 2024 Apr; 54(4):424-433. PubMed ID: 38251744
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. colorectal Carcinoma With Sarcomatoid Components: Report of 15 Cases and Literature Review of an Exceedingly Rare Carcinoma Subtype.
    Golconda U; McHugh KE; Allende DS; Collins K; Henn P; Lacambra M; Bejarano PA; Groisman GM; Loughrey MB; Monappa V; Zhang X; Hornick JL; Gonzalez RS
    Am J Surg Pathol; 2024 Apr; 48(4):465-474. PubMed ID: 38155543
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The heterogeneous impact of targeted therapy on the prognosis of stage III/IV colorectal cancer patients with different subtypes of tp53 mutations.
    Chen J; Chang X; Li X; Liu J; Wang N; Wu Y; Zheng L; Nie X
    Cancer Med; 2023 Dec; 12(24):21920-21932. PubMed ID: 38063316
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. TMUB1 expression is associated with the prognosis of colon cancer and immune cell infiltration.
    Lu Y; Wang K; Peng Y; Zhang J; Ju Q; Xu Q; Ouyang M; He Z
    PeerJ; 2023; 11():e16334. PubMed ID: 38025742
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy.
    Dong Y; Zheng M; Wang X; Yu C; Qin T; Shen X
    BMC Cancer; 2023 Nov; 23(1):1097. PubMed ID: 37950153
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Coiled-coil domain-containing 154 promotes colorectal cancer proliferation and metastasis via interacting with minichromosome maintenance complex component 2.
    Hong WF; Zhu DX; Chen YJ; Shen XZ; Cui YH; Du SS; Liu TS; Liang L
    Cancer Lett; 2023 Dec; 578():216460. PubMed ID: 37863352
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CLDN6 inhibits colorectal cancer proliferation dependent on restraining p53 ubiquitination via ZO-1/PTEN axis.
    Dong Y; Xu W; Qi D; Qu H; Jin Q; Sun M; Wang X; Quan C
    Cell Signal; 2023 Dec; 112():110930. PubMed ID: 37852424
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
    Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
    Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinicopathological features and prognosis of synchronous and metachronous colorectal cancer: a retrospective cohort study.
    Fan H; Wen R; Zhou L; Gao X; Lou Z; Hao L; Meng R; Gong H; Yu G; Zhang W
    Int J Surg; 2023 Dec; 109(12):4073-4090. PubMed ID: 37737848
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. High-throughput sequencing reveals Jatrorrhizine inhibits colorectal cancer growth by ferroptosis-related genes.
    Huang L; Sha Y; Liang W; Mo C; Li C; Deng Y; Gong W; Hou X; Ou M
    BMC Med Genomics; 2023 Sep; 16(1):217. PubMed ID: 37710311
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. RYBP contributes to improved prognosis in colorectal cancer via regulation of cell cycle, apoptosis and oxaliplatin sensitivity.
    Morinaka T; Sakai N; Takayashiki T; Kuboki S; Takano S; Ohira G; Matsubara H; Ohtsuka M
    Int J Oncol; 2023 Nov; 63(5):. PubMed ID: 37654197
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Apoptosis-related Prognostic Factors in Advanced colorectal cancer Determined Using Tissue Microarrays.
    Ozaki K; Sasaki K; Abe H; Nozawa H; Murono K; Emoto S; Ushiku T; Ishihara S
    Anticancer Res; 2023 Sep; 43(9):3935-3942. PubMed ID: 37648313
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Impacts of some clinicopathodemography and colorectal tissues key cell cycle and mucin stabilizing molecules on the metastasis trend in colorectal cancer patients.
    Ghorbani Ranjbary A; Mehrzad J; Rahbar N; Dehghani H
    Mol Biol Rep; 2023 Oct; 50(10):8589-8601. PubMed ID: 37644368
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 47.